ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 92 filers reported holding ADMA BIOLOGICS INC in Q1 2020. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,400,000 | -2.0% | 600,000 | +9.1% | 1.63% | -13.3% |
| Q3 2019 | $2,448,000 | +15.0% | 550,000 | 0.0% | 1.88% | +28.2% |
| Q2 2019 | $2,129,000 | -2.3% | 550,000 | -4.3% | 1.47% | -6.0% |
| Q1 2019 | $2,179,000 | +127.9% | 575,000 | +43.8% | 1.56% | +83.4% |
| Q4 2018 | $956,000 | -59.0% | 400,000 | +6.7% | 0.85% | -44.2% |
| Q3 2018 | $2,329,000 | +37.7% | 375,000 | 0.0% | 1.52% | +27.1% |
| Q2 2018 | $1,691,000 | +22.5% | 375,000 | +25.0% | 1.20% | +14.2% |
| Q1 2018 | $1,380,000 | -14.0% | 300,000 | -40.0% | 1.05% | -16.9% |
| Q4 2017 | $1,605,000 | – | 500,000 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 9,104,275 | $32,593,305 | 10.83% |
| Altium Capital Management LP | 2,723,011 | $9,748,379 | 5.08% |
| Velan Capital Investment Management LP | 1,736,100 | $6,215,238 | 5.01% |
| AWM Investment Company, Inc. | 5,999,872 | $21,479,542 | 3.17% |
| Mesirow Financial Investment Management, Inc. | 72,677 | $260,184 | 1.13% |
| Caligan Partners LP | 597,513 | $2,139,097 | 0.98% |
| Perceptive Advisors | 6,984,319 | $25,003,862 | 0.83% |
| OBERWEIS ASSET MANAGEMENT INC/ | 2,078,400 | $7,440,672 | 0.79% |
| TANG CAPITAL MANAGEMENT LLC | 1,360,000 | $4,868,800 | 0.69% |
| EAM Investors, LLC | 967,146 | $3,462,383 | 0.67% |